XML 45 R32.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

The Company’s RSU, RSA and PSA activity and related information as of and for the nine months ended September 30, 2020 were as follows (in millions, except per share amounts and years):


	Outstanding RSUs, RSAs and PSAs
	Number of Shares	Weighted Average Grant-Date Fair Value per Share		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value
Balance as of December 31, 2019	17.5	$	25.30
Granted(*)	7.4	22.32
Vested	(5.9)	25.95
Canceled	(2.0)	25.22
Balance as of September 30, 2020	17.0	$	23.79	1.2	$	364.9

________________________________

(*) Includes 6.2 million service-based, 0.8 million performance-based, and 0.4 million market-based RSUs and PSAs, as applicable. The number of shares subject to performance-based and market-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.

Schedule of employee stock purchases through ESPP

The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Shares purchased	1.3		1.2		2.7		2.4
Average exercise price per share	$	19.68	$	22.03	$	19.59	$	22.04

Schedule of employee service share-based compensation, allocation of recognized period costs

Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and the ESPP was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Cost of revenues - Product	$	1.4	$	0.8	$	3.9	$	4.3
Cost of revenues - Service	4.0		4.1		11.6		13.0
Research and development	22.9		29.6		57.1		68.0
Sales and marketing	16.4		15.5		43.4		40.0
General and administrative	8.0		7.5		22.7		21.8
Total	$	52.7	$	57.5	$	138.7	$	147.1

Disclosure of share-based compensation arrangements by share-based payment award

The following table summarizes share-based compensation expense by award type (in millions):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Stock options	$	1.5	$	2.3	$	5.2	$	5.6
RSUs, RSAs, and PSAs	45.8		50.9		118.0		127.7
ESPP	5.4		4.3		15.5		13.8
Total	$	52.7	$	57.5	$	138.7	$	147.1